Pharmacokinetics of Triphala Guggulu
Not Applicable
- Registration Number
- CTRI/2022/11/046987
- Lead Sponsor
- Dr Neelam Rawat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All Age Groups
Healthy Volunteers willing to sign Informed consent form (ICF)
Exclusion Criteria
Any serious medical & seriously ill patients.
Volunteers on any previous medication.
Volunteers consuming alcohol, chewing tobacco and cigarette smoking.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To analyse the disintegration of Guggulu Tablet at regular intervals of 2,4,8 and 24 hrs. <br/ ><br>2.To analyse the disintegration of Triphala Guggulu Tablet at regular intervals of 2,4,8 and 24 hrs.Timepoint: 24 hrs
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI